We are a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases.
$16.00 - $18.00
July 18, 2019
MORGAN STANLEY & CO. LLC,LEERINK SWANN & COMPANY
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Fulcrum Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277